Adiponectin, obesity, and cardiovascular disease

M Fasshauer, R Paschke, M Stumvoll - Biochimie, 2004 - Elsevier
Several adipocyte-secreted factors have been demonstrated to potentially link obesity,
insulin resistance, and cardiovascular disease. Among those, adiponectin is an insulin …

Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease

Y Matsuzawa - Atherosclerosis supplements, 2005 - Elsevier
Adiponectin is the most abundant adipose-specific protein. Its expression is reduced in
obesity, insulin resistance and type 2 diabetes, and plasma concentrations are inversely …

The role of adiponectin in obesity, diabetes, and cardiovascular disease

J Kawano, R Arora - Journal of the cardiometabolic syndrome, 2009 - Wiley Online Library
Nearly 1 in 4 adults in the United States is obese. The connection between obesity and
insulin resistance, type 2 diabetes, and cardiovascular disease is a well researched one …

[HTML][HTML] Role of adiponectin in metabolic and cardiovascular disease

S Lee, HB Kwak - Journal of exercise rehabilitation, 2014 - ncbi.nlm.nih.gov
Under disease conditions including obesity (insulin resistance) and diabetes, dysregulation
of adipokines such as tumor necrosis factor (TNF)-α, leptin, resistin, and adiponectin …

Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases

T Yamauchi, T Kadowaki - International journal of obesity, 2008 - nature.com
Adiponectin and adiponectin receptors (AdipoRs) have been found to play significant roles
in the etiology of obesity-related chronic disease. Their discovery has been a long and …

Modulation of adiponectin as a potential therapeutic strategy

S Lim, MJ Quon, KK Koh - Atherosclerosis, 2014 - Elsevier
Adiponectin is produced predominantly by adipocytes and plays an important role in
metabolic and cardiovascular homeostasis through its insulin-sensitizing actions and anti …

Adiponectin: linking the metabolic syndrome to its cardiovascular consequences

KR Rabin, Y Kamari, I Avni, E Grossman… - Expert review of …, 2005 - Taylor & Francis
Obesity and its related disorders, glucose intolerance, hypertension and hyperlipidemia,
collectively named the metabolic syndrome, result in substantial cardiovascular morbidity …

Adiponectin and cardiovascular health: an update

X Hui, KSL Lam, PM Vanhoutte… - British journal of …, 2012 - Wiley Online Library
The global epidemic of obesity is accompanied by an increased prevalence of
cardiovascular disease (CVD), in particular stroke and heart attack. Dysfunctional adipose …

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

C Lara-Castro, Y Fu, BH Chung… - Current opinion in …, 2007 - journals.lww.com
Recent studies emphasize the role played by adiponectin in the homeostasis of adipose
tissue and in the pathogenesis of the metabolic syndrome, type 2 diabetes, and …

Adiponectin and its role in cardiovascular diseases

J Beltowski, A Jamroz-Wisniewska… - … Formerly Current Drug …, 2008 - ingentaconnect.com
Studies performed during the last decade indicate that adipose tissue is not only a site of
triglyceride storage but also an active endocrine organ which secretes many biologically …